Literature DB >> 35738846

Repolarization Heterogeneity in Human Post-Infarct Ventricular Tachycardia.

David J Callans1, J Kevin Donahue2.   

Abstract

BACKGROUND: Slow conduction, caused by fibrosis between surviving myocytes and connexin remodeling, is an important prerequisite for post-infarction ventricular tachycardia (VT); however, slow conduction is present throughout the infarct whereas VT circuits are finite in number and discrete. In a porcine model of VT, re-entrant circuits occur at region of significant repolarization heterogeneity caused by up-regulation of potassium channel β-subunits KCNE3 (increasing repolarization current) and KCNE4 (decreasing repolarization current), causing heterogeneous action potential durations.
OBJECTIVES: This study was designed to determine whether re-entrant circuits in human post-infarction VT are associated with repolarization heterogeneity.
METHODS: In 6 patients, left ventricular mapping was performed during induced VT to identify sites within the VT circuit. Subsequently, unipolar mapping (3.5-mm tip ablation catheter) was performed to characterize activation-recovery intervals (ARIs), which are surrogates for local action potential durations, at sites documented within the VT circuit isthmus (IN) compared to sites within the infarct scar but outside of the VT circuit (OUT).
RESULTS: ARIs were significantly shorter in the IN compared with the OUT sites (420.2 ± 79.3 ms vs 462 ± 52.8 ms; P = 0.01). In all patients. sites that were associated with the circuit always had shorter ARI values than did those sampled from OUT regions.
CONCLUSIONS: VT circuit sites in human post-infarct VT are associated with repolarization heterogeneity, similar to what was previously reported in a porcine model. This suggests the possibility of a common mechanism between humans and the porcine model of post-infarct VT, and that development of ablation strategies or small molecule or genetic therapies to restore normal repolarization kinetics may be antiarrhythmic.
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cellular electrophysiology; molecular therapy; myocardial infarction; ventricular tachycardia

Mesh:

Year:  2022        PMID: 35738846      PMCID: PMC9236155          DOI: 10.1016/j.jacep.2022.03.002

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  24 in total

1.  Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation.

Authors:  J M de Bakker; F J van Capelle; M J Janse; A A Wilde; R Coronel; A E Becker; K P Dingemans; N M van Hemel; R N Hauer
Journal:  Circulation       Date:  1988-03       Impact factor: 29.690

2.  Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia.

Authors:  M G Kienzle; J Miller; R A Falcone; A Harken; M E Josephson
Journal:  Circulation       Date:  1984-12       Impact factor: 29.690

3.  Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study.

Authors:  Mohit K Turagam; Venkat Vuddanda; Donita Atkins; Pasquale Santangeli; David S Frankel; Roderick Tung; Marmar Vaseghi; William H Sauer; Wendy Tzou; Nilesh Mathuria; Shiro Nakahara; Timm M Dickfeld; T Jared Bunch; Peter Weiss; Luigi Di Biase; Venkat Tholakanahalli; Kairav Vakil; Usha B Tedrow; William G Stevenson; Paolo Della Bella; Kalyanam Shivkumar; Francis E Marchlinski; David J Callans; Andrea Natale; Madhu Reddy; Dhanunjaya Lakkireddy
Journal:  JACC Clin Electrophysiol       Date:  2017-11-15

4.  Molecular ablation of ventricular tachycardia after myocardial infarction.

Authors:  Tetsuo Sasano; Amy D McDonald; Kan Kikuchi; J Kevin Donahue
Journal:  Nat Med       Date:  2006-10-29       Impact factor: 53.440

5.  Prophylactic catheter ablation for the prevention of defibrillator therapy.

Authors:  Vivek Y Reddy; Matthew R Reynolds; Petr Neuzil; Allison W Richardson; Milos Taborsky; Krit Jongnarangsin; Stepan Kralovec; Lucie Sediva; Jeremy N Ruskin; Mark E Josephson
Journal:  N Engl J Med       Date:  2007-12-27       Impact factor: 91.245

6.  Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States.

Authors:  Chandrasekar Palaniswamy; Dhaval Kolte; Prakash Harikrishnan; Sahil Khera; Wilbert S Aronow; Marjan Mujib; William Michael Mellana; Paul Eugenio; Seth Lessner; Aileen Ferrick; Gregg C Fonarow; Ali Ahmed; Howard A Cooper; William H Frishman; Julio A Panza; Sei Iwai
Journal:  Heart Rhythm       Date:  2014-07-09       Impact factor: 6.343

7.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

Authors:  John L Sapp; George A Wells; Ratika Parkash; William G Stevenson; Louis Blier; Jean-Francois Sarrazin; Bernard Thibault; Lena Rivard; Lorne Gula; Peter Leong-Sit; Vidal Essebag; Pablo B Nery; Stanley K Tung; Jean-Marc Raymond; Laurence D Sterns; George D Veenhuyzen; Jeff S Healey; Damian Redfearn; Jean-Francois Roux; Anthony S L Tang
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245

8.  Epicardial activation and repolarization patterns in patients with right ventricular hypertrophy.

Authors:  P S Chen; K M Moser; W P Dembitsky; W R Auger; P O Daily; C M Calisi; S W Jamieson; G K Feld
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

9.  Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.

Authors:  Karl-Heinz Kuck; Anselm Schaumann; Lars Eckardt; Stephan Willems; Rodolfo Ventura; Etienne Delacrétaz; Heinz-Friedrich Pitschner; Josef Kautzner; Burghard Schumacher; Peter S Hansen
Journal:  Lancet       Date:  2010-01-02       Impact factor: 79.321

10.  Assessment of a conduction-repolarisation metric to predict Arrhythmogenesis in right ventricular disorders.

Authors:  C A Martin; M Orini; N T Srinivasan; J Bhar-Amato; S Honarbakhsh; A W Chow; M D Lowe; R Ben-Simon; P M Elliott; P Taggart; P D Lambiase
Journal:  Int J Cardiol       Date:  2018-05-20       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.